TrialThe international journal of neuropsychopharmacology2022

Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.

Zhiwei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.